M&T Bank’s Standard BioTools LAB Stock Holding History

M&T Bank’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.7K	Sell	23,643 -265	-1%	-$321	﹤0.01%	1682
2025 Q4	$30.6K	Buy	+23,908	New	+$32.1K	﹤0.01%	1670
2015 Q4	–	Sell	-26,175	Closed	-$212K	–	1808
2015 Q3	$212K	Buy	26,175 +8,965	+52%	+$141K	﹤0.01%	1502
2015 Q2	$416K	Buy	+17,210	New	+$543K	﹤0.01%	1316

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

M&T Bank's LAB Position: Q1 2026 in Review

M&T Bank reduced its Standard BioTools (LAB) stake by 1.1% in Q1 2026, selling an estimated $321 and leaving 23,643 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

M&T Bank first reported a position in LAB in Q2 2015 and has held it in 4 quarters since. The position peaked at $416K in Q2 2015. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

M&T Bank held 23,643 shares of Standard BioTools worth $21.7K as of Q1 2026.
M&T Bank sold 265 Standard BioTools shares in Q1 2026, an estimated $321.
Standard BioTools made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1682 holding.
M&T Bank first reported a position in Standard BioTools in Q2 2015 and has held it in 4 quarters since.
M&T Bank's Standard BioTools position peaked at $416K in Q2 2015.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.